Literature DB >> 10600639

Characterization of plasma unsaturated lysophosphatidylcholines in human and rat.

M Croset1, N Brossard, A Polette, M Lagarde.   

Abstract

Unsaturated lysophosphatidylcholines (lysoPtdCho) bound to albumin circulate in blood plasma and seem to be a novel transport system for carrying polyunsaturated fatty acids (PUFA) to tissues that are rich in these fatty acids, such as the brain. The potential of these lysoPtdCho as a significant source of PUFA for cells has been assessed by comparing their plasma concentration with that of unsaturated non-esterified fatty acids (NEFA) bound to albumin. In humans, the PUFA concentration was 25.9+/-3.1 nmol/ml for these lysoPtdCho, compared with 33.4+/-9.6 nmol/ml for NEFA; in rats the equivalent values are 14.2+/-0.6 and 13.1+/-1.1 nmol/ml respectively (means+/-S.E.M.). The lysoPtdCho arachidonic acid content was 2-fold (human) and 5-fold (rat) higher than that of NEFA. In human and rat plasma, unsaturated lysoPtdCho were associated mainly with albumin rather than lipoproteins. The rate and extent of the acyl group shift from the sn-2 to sn-1 position of these lysoPtdCho were studied by the incubation of 1-lyso, 2-[(14)C]C(18:2)n-6-glycerophosphocholine (GPC) with plasma. The rapid isomerization of this lipid occurred at pH 7 (20% isomerization within 2 min) and was not prevented by its association with albumin. The position of the acyl group in the lysoPtdCho circulating in plasma was studied by collecting blood directly in organic solvents containing 1-lyso,2-[(14)C]C(18:2)n-6-GPC as a marker of isomerization that occurred during sampling and analysis. Approx. 50% of the PUFA was located at the sn-2 position, demonstrating that substantial concentrations of 2-acyl-lysoPtdCho are present in plasma and are available for tissue uptake, where they can be reacylated at the sn-1 position to form membrane phospholipids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10600639      PMCID: PMC1220730     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells.

Authors:  N Brossard; M Croset; S Normand; J Pousin; J Lecerf; M Laville; J L Tayot; M Lagarde
Journal:  J Lipid Res       Date:  1997-08       Impact factor: 5.922

2.  1-Acyl-2-lysophosphatidylcholine transport across the blood-retina and blood-brain barrier.

Authors:  M Alberghina; S Infarinato; C D Anfuso; G Lupo
Journal:  FEBS Lett       Date:  1994-09-05       Impact factor: 4.124

3.  Metabolism of lysolecithin in vivo and in vitro with particular emphasis on the arterial wall.

Authors:  O W Portman; D R Illingworth
Journal:  Biochim Biophys Acta       Date:  1974-04-26

4.  Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat.

Authors:  G Sekas; G M Patton; E C Lincoln; S J Robins
Journal:  J Lab Clin Med       Date:  1985-02

5.  Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition.

Authors:  K N Frayn; S Shadid; R Hamlani; S M Humphreys; M L Clark; B A Fielding; O Boland; S W Coppack
Journal:  Am J Physiol       Date:  1994-03

6.  Stable isotope tracer and gas-chromatography combustion isotope ratio mass spectrometry to study the in vivo compartmental metabolism of docosahexaenoic acid.

Authors:  N Brossard; C Pachiaudi; M Croset; S Normand; J Lecerf; V Chirouze; J P Riou; J L Tayot; M Lagarde
Journal:  Anal Biochem       Date:  1994-07       Impact factor: 3.365

7.  Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain.

Authors:  F Thies; C Pillon; P Moliere; M Lagarde; J Lecerf
Journal:  Am J Physiol       Date:  1994-11

8.  Incorporation and turnover of eicosapentaenoic and docosahexaenoic acids in human blood platelets in vitro.

Authors:  M Croset; Y Bayon; M Lagarde
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

9.  The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin.

Authors:  A E Thumser; J E Voysey; D C Wilton
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

10.  Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2 arachidonoyl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters.

Authors:  P V Subbaiah; M Liu; P J Bolan; F Paltauf
Journal:  Biochim Biophys Acta       Date:  1992-09-22
View more
  88 in total

1.  Synthesis and Identification of AceDoxyPC, a Protectin-Containing Structured Phospholipid, Using Liquid Chromatography/Mass Spectrometry.

Authors:  Amanda Lo Van; Baptiste Fourmaux; Madeleine Picq; Michel Guichardant; Michel Lagarde; Nathalie Bernoud-Hubac
Journal:  Lipids       Date:  2017-08-03       Impact factor: 1.880

Review 2.  Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.

Authors:  Robert S Rosenson; Diana M Stafforini
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

3.  Synthesis of acetyl,docosahexaenoyl-glycerophosphocholine and its characterization using nuclear magnetic resonance.

Authors:  A Polette; C Deshayes; B Chantegrel; M Croset; J M Armstrong; M Lagarde
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

Review 4.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids.

Authors:  Yi Xiao; F Peter Guengerich
Journal:  J Lipid Res       Date:  2012-05-16       Impact factor: 5.922

6.  Dietary lysophosphatidylcholine-EPA enriches both EPA and DHA in the brain: potential treatment for depression.

Authors:  Poorna C R Yalagala; Dhavamani Sugasini; Sridevi Dasarathi; Kalipada Pahan; Papasani V Subbaiah
Journal:  J Lipid Res       Date:  2018-12-10       Impact factor: 5.922

7.  Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma.

Authors:  Shih-Chi Su; Xiaoxiao Hu; Patrick A Kenney; Megan M Merrill; Kara N Babaian; Xiu-Ying Zhang; Tapati Maity; Shun-Fa Yang; Xin Lin; Christopher G Wood
Journal:  Clin Cancer Res       Date:  2013-10-11       Impact factor: 12.531

8.  Lysophosphatidyl choline modulates mechanosensitive L-type Ca2+ current in circular smooth muscle cells from human jejunum.

Authors:  Robert E Kraichely; Peter R Strege; Michael G Sarr; Michael L Kendrick; Gianrico Farrugia
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

9.  Oxygenation of 1-docosahexaenoyl lysophosphatidylcholine by lipoxygenases; conjugated hydroperoxydiene and dihydroxytriene derivatives.

Authors:  Long Shuang Huang; Mee Ree Kim; Dai-Eun Sok
Journal:  Lipids       Date:  2007-09-19       Impact factor: 1.880

Review 10.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.